Wai Yuen Tong Medicine Holdings Limited provided consolidated earnings guidance for the six months ended September 30, 2016. For the six months, the company expected loss attributable to owners of the parent as compared to the profit attributable to owners of the parent in the corresponding period in 2015. The primary reasons for the expected deterioration of results performance, among other things, are: (1) a loss in fair value of equity investments at fair value through profit or loss (net) is recorded in 2016 whereas a gain in fair value of equity investments at fair value (net) was recorded in 2015; and (2) a share of losses in associates is expected to be recorded for 2016 whereas a share of profit in an associate was recorded in 2015; which were offset by the effect that a loss on deemed partial disposal of equity interests in an associate was accounted for in 2015 whereas there is no such loss in 2016 and a gain on disposal of a property is realised in 2016.